Literature DB >> 3587921

Acute posterior multifocal placoid pigment epitheliopathy and late-onset meningo-encephalitis.

D H Kersten, S Lessell, T J Carlow.   

Abstract

A steroid-sensitive meningo-encephalopathy developed in a healthy young woman 5 1/2 years after the occurrence of acute posterior multifocal placoid pigment epitheliopathy (APMPPE). The association of APMPPE with systemic and neurologic inflammatory disorders has been well documented, but to the knowledge of the authors, this is the first report of an APMPPE patient in which there was delayed onset of the meningo-encephalopathy. The association with dermal vasculitis, nephropathy, meningo-encephalitis, cerebral vasculitis, and thyroiditis suggests that APMPPE may be one manifestation of a diffuse systemic inflammatory condition.

Entities:  

Mesh:

Year:  1987        PMID: 3587921     DOI: 10.1016/s0161-6420(87)33434-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  5 in total

1.  Acute posterior multifocal placoid pigment epitheliopathy with cerebral involvement.

Authors:  G Stoll; K Reiners; A Schwartz; F G Kaup; C Althaus; H J Freund
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-01       Impact factor: 10.154

2.  [Juvenile pontine infarction. Complication of acute posterior multifocal placoid pigment epitheliopathy].

Authors:  M Poppenborg; W Schäbitz; M Rauch; G Spital
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

3.  Acute posterior multifocal placoid pigment epitheliopathy complicated by central retinal vein occlusion.

Authors:  D G Charteris; V Khanna; B Dhillon
Journal:  Br J Ophthalmol       Date:  1989-09       Impact factor: 4.638

Review 4.  Acute posterior multifocal placoid pigment epitheliopathy.

Authors:  N P Jones
Journal:  Br J Ophthalmol       Date:  1995-04       Impact factor: 4.638

5.  Neurological Manifestations of Acute Posterior Multifocal Placoid Pigment Epitheliopathy.

Authors:  Hussein Algahtani; Ashjan Alkhotani; Bader Shirah
Journal:  J Clin Neurol       Date:  2016-10       Impact factor: 3.077

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.